CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zhejiang Huahai Pharmaceutical Company Snapshot
Zhejiang Huahai Pharmaceutical operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Huahai Pharmaceutical with three other companies in this sector in China: Tianjin Chase Sun Pharmaceutical Company Limited (2016 sales of 3.87 billion Chinese Renmimbi [US$582.83 million] of which 49% was Granules), Shijiazhuang Yiling Pharmaceutical Co Ltd (3.82 billion Chinese Renmimbi [US$575.75 million] of which 100% was Medicine), and Shenzhen Salubris Pharmaceuticals Co Ltd (3.83 billion Chinese Renmimbi [US$577.78 million] of which 100% was Pharmaceutical Manufacturing).

Sales Analysis. Zhejiang Huahai Pharmaceutical reported sales of 4.09 billion Chinese Renmimbi (US$616.87 million) for the year ending December of 2016. This represents an increase of 16.9% versus 2015, when the company's sales were 3.50 billion Chinese Renmimbi. Sales at Zhejiang Huahai Pharmaceutical have increased during each of the previous five years (and since 2011, sales have increased a total of 124%). Sales of Technical Service saw an increase that was more than double the company's growth rate: sales were up 250.0% in 2016, from 4.39 million Chinese Renmimbi to 15.37 million Chinese Renmimbi. Zhejiang Huahai Pharmaceutical also saw significant increases in sales in Drug Sale (up 22.3% to 1.96 billion Chinese Renmimbi) . Not all segments of Zhejiang Huahai Pharmaceutical experienced an increase in sales in 2016: sales of Other fell 100.0% to 12,478.64 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhejiang Huahai Pharmaceutical
  Stock Performance Chart for Zhejiang Huahai Pharmaceutical
 
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 25.02
(Figures in Chinese Renmimbi)
1 Week 2.6%   13 Weeks 5.8%  
4 Weeks 29.0%   52 Weeks 3.2%  
 
Zhejiang Huahai Pharmaceutical Key Data:
  Ticker: 600521 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,092,792,848
(Year Ending Jan 2017).
Employees: 5,275
  Currency: Chinese Renmimbi Market Cap: 26,083,108,107
  Fiscal Yr Ends: December Shares Outstanding: 1,042,490,332
  Share Type: A Gu Closely Held Shares: 522,245,627
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.